Influence of Brain Insulin Sensitivity on Peripheral Insulin Sensitivity
NCT ID: NCT01847456
Last Updated: 2013-12-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
10 participants
INTERVENTIONAL
2013-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
"Effect of Central Insulin Administration on Whole-body Insulin Sensitivity in Women"
NCT03929419
Central Insulin Sensitivity in Individuals With Type 2 Diabetes (T2D) and at Risk for Developing T2D
NCT05856877
Influence of Central Nervous Insulin Sensitivity on Insulin Secretion
NCT02870361
The Effect of Central Insulin on Insulin Sensitivity and Energy Metabolism
NCT01479075
Effects of Age and Obesity on Brain Insulin Sensitivity
NCT04372849
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
insulin nasal spray
160 Units of human insulin as nasal spray
human insulin as nasal spray
Placebo nasal spray
Nasalspray containing placebo solution
Placebo
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
human insulin as nasal spray
Placebo
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* normal HbA1c
* healthy volunteers
Exclusion Criteria
* metal implants
* cardial diseases
* anemia
* patients taking any kind of drugs
18 Years
35 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital Tuebingen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
andreas fritsche
Professor of Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Tuebingen, Internal medicine IV
Tübingen, , Germany
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Heni M, Wagner R, Kullmann S, Veit R, Mat Husin H, Linder K, Benkendorff C, Peter A, Stefan N, Haring HU, Preissl H, Fritsche A. Central insulin administration improves whole-body insulin sensitivity via hypothalamus and parasympathetic outputs in men. Diabetes. 2014 Dec;63(12):4083-8. doi: 10.2337/db14-0477. Epub 2014 Jul 15.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SFB 997 A01 WP7
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.